26财政年度前半期,在更高诊断和扩展的驱动下,Chandan Healthcare实现了23%的收入增长和47%的利润增长。 Chandan Healthcare saw 23% revenue growth and 47% profit rise in first half of FY26, driven by higher diagnostics and expansion.

钱丹医疗报告说,2026财年上半年,收入增长23%,达到1.37亿卢比,净利增长47%至16.6亿卢比,主要原因是诊断量增加,业务组合改善和成本控制. Chandan Healthcare reported a 23% increase in revenue to ₹137 crore and a 47% rise in net profit to ₹16 crore for the first half of fiscal year 2026, driven by higher diagnostic volumes, improved business mix, and cost control. EBITDA的增长率为44%,达到%30,利润幅度扩大至21.8%。 EBITDA grew 44% to ₹30 crore, with margins expanding to 21.8%. 该公司扩大了网络,在Patna、Lucknow和Ayodhya建立了新中心,与Jeena Sikhko人寿护理公司建立了战略伙伴关系,并计划通过拥有和特许模式在印度各地发展。 The company expanded its network with new centers in Patna, Lucknow, and Ayodhya, launched a strategic partnership with Jeena Sikho Lifecare, and plans to grow across India through owned and franchise models.